AzTrials
AzTrials

Thorax TraumasTraumaThoraxNCT04123977

Evaluation of Patient Analgesia After Bloc Serratus

An observational study of Thorax Traumas, run by University Hospital, Strasbourg, France at 1 site in France.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Thorax traumas are very common in severe traumatology, including road accidents, representing the second most frequent site (after head injury, according to the FIRST study). These thoracic lesions are the cause of many complications (pneumothorax, hemothorax, lung infections, atelectasis). Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Thorax Traumas
How many people
100 participants
Where
1 siteFrance
Study dates
1 Oct 2019to Oct 2020
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Patient hospitalised in surgical intensive care or continuous trauma care with thorax trauma who received anterior Serratus block analgesia from January 1, 2018 to February 28, 2019

Who may be able to join

  • Adult patient (≥18 years old)
  • Gender (Male and Female)
  • Patient hospitalised in surgical intensive care or continuous trauma care with thorax trauma who received anterior Serratus block analgesia from January 1, 2018 to February 28, 2019
  • Patient who has given his consent to the reuse of his data for the purposes of this research
  • Criteria for non-inclusion:
  • Patient who has expressed opposition to participating in the study
Show all 9Show fewer
  • Impossibility of giving the subject informed information (difficulties in understanding the subject,...)
  • Subject under the protection of justice
  • Subject under guardianship or curatorship

Who cannot join

None listed.

Trial locations and contacts

1 site in 1 country.

France1 site, 1 recruiting
  • Service de Réanimation chirurgicale_ Hôpital de Hautepierre

    Strasbourg, 67091

    Julien POTTECHER, MD, PhD, 33 3 88 12 70 95, julien.pottecher@chru-strasbourg.fr

    Kevin COGNE, MD, 33 3 88 12 61 55, kevin.cogne@chru-strasbourg.fr

    Recruiting

Other trials in France

About this study

Official title: Evaluation of Patient Analgesia After Bloc Serratus for the Management of Thoracic Trauma

Thorax traumas are very common in severe traumatology, including road accidents, representing the second most frequent site (after head injury, according to the FIRST study). These thoracic lesions are the cause of many complications (pneumothorax, hemothorax, lung infections, atelectasis).

The national recommendations recommend the use of multi-modal analgesia with the use of regional loco anaesthesia for pain management and prevention of respiratory complications, including infectious complications. The loco-regional anaesthesia of choice is thoracic epidural or paravertebral block, but these techniques are not without risks, and are contraindicated in many situations (severe head trauma, patient under curative anticoagulation, pelvic trauma...).

Read more

The anterior Serratus block appears to be a quality localoregional anaesthesia in thoracic surgery, and a few cases in the literature have shown an interest in severe traumatology.

The investigators perform this anterior Serratus block almost systematically in patients with thoracic trauma in the Hautepierre surgical intensive care unit.

Conditions
Thorax Traumas
Keywords
thorax trauma, head injury, Multi-modal analgesia, Paravertebral block, Thoracic epidural, Serratus Block
Medical subject headings
Craniocerebral Trauma

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Retrospective analysis of analgesia after Bloc serratus

    Measured: Files analysed retrospectily from January 1st, 2018 to February 28, 2019 will be examined

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Oct 2019
  2. Study start1 Oct 2019
  3. Primary completionOct 2020 (estimated)
  4. Study completionOct 2020 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Retrospective
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04123977
Sponsor's protocol ID
7406
Acronym
TraumaThorax
Status last verified
Oct 2019
First submitted
3 Oct 2019
Last updated
21 Oct 2019
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Thorax Traumas, run by University Hospital, Strasbourg, France at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 21 Oct 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Julien POTTECHER, MD, PhD (33 3 88 12 70 95, julien.pottecher@chru-strasbourg.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Retrospective analysis of analgesia after Bloc serratus (time frame: Files analysed retrospectily from January 1st, 2018 to February 28, 2019 will be examined). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Oct 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in